| 000 | 01704 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513215942.0 | ||
| 264 | 0 | _c20000831 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.55.4.585 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKanda, T | |
| 245 | 0 | 0 |
_aAnti-GM1 antibody facilitates leakage in an in vitro blood-nerve barrier model. _h[electronic resource] |
| 260 |
_bNeurology _cAug 2000 |
||
| 300 |
_a585-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 | _aCarbon Radioisotopes |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCauda Equina _xblood supply |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aComplement System Proteins _xpharmacology |
| 650 | 0 | 4 | _aDiffusion Chambers, Culture |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectric Impedance |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
| 650 | 0 | 4 |
_aG(M1) Ganglioside _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInulin _xpharmacokinetics |
| 650 | 0 | 4 |
_aLymphokines _xpharmacology |
| 650 | 0 | 4 |
_aMetabolic Clearance Rate _xdrug effects |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 700 | 1 | _aIwasaki, T | |
| 700 | 1 | _aYamawaki, M | |
| 700 | 1 | _aTai, T | |
| 700 | 1 | _aMizusawa, H | |
| 773 | 0 |
_tNeurology _gvol. 55 _gno. 4 _gp. 585-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.55.4.585 _zAvailable from publisher's website |
| 999 |
_c10901786 _d10901786 |
||